The stock's fall snapped a two-day winning streak.

A Peninsula biotech company is making a dramatic pivot, leaving behind its focus on inflammatory diseases for a surprising ...

Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.

Detailed price information for Pheton Holdings Ltd Cl A (PTHL-Q) from The Globe and Mail including charting and trades.

Ten grants funded through the first round of the Guiding Local Opportunities for Wellbeing (GLOWS) Indigenous Health Grant program spanning ...

Over 60% of patients who received ervogastat plus clesacostat for 48 weeks achieved MASH resolution without fibrosis ...

The largest group of Black physicians, thought leaders, and celebrities were in one room to have a needed discussion about HIV.

This was the stock's second consecutive day of gains.

On Monday, Gilead Sciences GILD got an upgrade for its IBD SmartSelect Composite Rating from 92 to 96. Looking For Winning ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

On July 16, 49 attorneys general (AGs) announced that they joined a $202 million settlement with Gilead Sciences, Inc. (Gilead). Previously ...

The second-quarter earnings season for the drug and biotech sector accelerated last week and will be in full swing this week, ...